Acadian Asset Management
NVCR icon

Acadian Asset Management’s NovoCure NVCR Stock Holding History

Acadian Asset Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.95M Sell
261,146
-1,001
-0.4% -$15.1K ﹤0.01% 875
2026
Q1 		$2.85M Buy
262,147
+3,069
+1% +$38.3K ﹤0.01% 851
2025
Q4 		$3.34M Buy
259,078
+50,170
+24% +$644K 0.01% 763
2025
Q3 		$2.69M Buy
208,908
+156,383
+298% +$2.09M ﹤0.01% 815
2025
Q2 		$929K Buy
52,525
+47,596
+966% +$829K ﹤0.01% 995
2025
Q1 		$87K Buy
+4,929
New +$112K ﹤0.01% 1371
2024
Q4 		– Sell
-8,712
Closed -$136K – 2010
2024
Q3 		$136K Buy
+8,712
New +$158K ﹤0.01% 1494
2024
Q2 		– Sell
-3,143
Closed -$49K – 1864
2024
Q1 		$49K Sell
3,143
-39,554
-93% -$582K ﹤0.01% 1384
2023
Q4 		$634K Buy
42,697
+37,319
+694% +$499K ﹤0.01% 970
2023
Q3 		$85K Buy
+5,378
New +$155K ﹤0.01% 1336
2021
Q1 		– Sell
-3,091
Closed -$536K – 2239
2020
Q4 		$536K Buy
3,091
+2,026
+190% +$277K ﹤0.01% 1216
2020
Q3 		$119K Sell
1,065
-1,067
-50% -$85.3K ﹤0.01% 1610
2020
Q2 		$126K Buy
2,132
+109
+5% +$7.17K ﹤0.01% 1654
2020
Q1 		$137K Buy
2,023
+775
+62% +$61.2K ﹤0.01% 1283
2019
Q4 		$105K Buy
+1,248
New +$101K ﹤0.01% 1438

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Acadian Asset Management's NVCR Position: Q2 2026 in Review

Acadian Asset Management reduced its NovoCure (NVCR) stake by 0.38% in Q2 2026, selling an estimated $15.1K and leaving 261,146 shares worth $3.95M. The position accounts for ﹤0.01% of the portfolio, ranked #875.

Acadian Asset Management first reported a position in NVCR in Q4 2019 and has held it in 15 quarters since. 216 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Acadian Asset Management held 261,146 shares of NovoCure worth $3.95M as of Q2 2026.
  • Acadian Asset Management sold 1,001 NovoCure shares in Q2 2026, an estimated $15.1K.
  • NovoCure made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #875 holding.
  • Acadian Asset Management first reported a position in NovoCure in Q4 2019 and has held it in 15 quarters since.
  • 216 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.